Balakrishnan A
Cambridge Hepatopancreatobiliary Unit and MRC Cancer Unit, Addenbrooke's Hospital and University of Cambridge , Cambridge , UK.
Ann R Coll Surg Engl. 2018 Mar;100(3):165-171. doi: 10.1308/rcsann.2017.0174. Epub 2018 Jan 24.
Short bowel syndrome occurs following the loss of a large portion of functional intestine and is associated with high morbidity and mortality. The intestine exhibits pronounced diurnal rhythms in glucose absorption and mounts a profound proliferative response following massive small bowel resection. Understanding the molecular pathways that underpin this could yield novel treatment options. Two in vivo models were employed using the nocturnally active Sprague Dawley® rat, namely daytime feeding and massive small bowel resection. Glucose absorption exhibited a 24-hour periodicity in the gut and peaked during maximal nutrient delivery, mediated by rhythms in the glucose transporter sodium glucose co-transporter 1 (SGLT1). Feeding during the day shifted the peak in the circadian clock gene PER1 and SGLT1. RNA interference and luciferase assays demonstrated that PER1 transcriptionally regulates SGLT1, linking for the first time clock genes and intestinal glucose absorption. Intestinal proliferation also exhibited diurnal rhythmicity, with peak absorptive surface area occurring during maximal nutrient availability. mir-16 is diurnally expressed in intestinal crypts, exhibiting minimal expression during maximal nutritional availability. mir-16 overexpression increased apoptosis and arrested proliferation in vitro. mir-125a was upregulated in intestinal crypts following 80% small bowel resection, and induced apoptosis and growth arrest upon overexpression in vitro. This work provides novel insights into the role of circadian clock genes, intestinal transporters and microRNAs in regulating intestinal absorption and proliferation and is the first demonstration of a role for microRNAs in these adaptive phenomena. Modulation of these pathways may represent a new therapeutic option for the management of short bowel syndrome.
短肠综合征发生在大部分功能性肠段丧失之后,与高发病率和死亡率相关。肠道在葡萄糖吸收方面呈现出明显的昼夜节律,并且在大规模小肠切除术后会产生强烈的增殖反应。了解其背后的分子途径可能会产生新的治疗选择。使用夜行性的斯普拉格·道利®大鼠建立了两种体内模型,即白天喂食和大规模小肠切除。葡萄糖吸收在肠道中呈现24小时周期性,并在最大营养供应期间达到峰值,这是由葡萄糖转运蛋白钠葡萄糖协同转运蛋白1(SGLT1)的节律介导的。白天喂食会使昼夜节律基因PER1和SGLT1的峰值发生偏移。RNA干扰和荧光素酶测定表明,PER1转录调控SGLT1,首次将生物钟基因与肠道葡萄糖吸收联系起来。肠道增殖也呈现昼夜节律性,在最大营养可利用性期间吸收表面积达到峰值。mir-16在肠隐窝中呈昼夜表达,在最大营养可利用性期间表达最低。mir-16过表达会增加体外细胞凋亡并阻止增殖。在80%小肠切除术后,mir-125a在肠隐窝中上调,并且在体外过表达时会诱导细胞凋亡和生长停滞。这项工作为昼夜节律基因、肠道转运蛋白和微小RNA在调节肠道吸收和增殖中的作用提供了新的见解,并且首次证明了微小RNA在这些适应性现象中的作用。调节这些途径可能代表了治疗短肠综合征的一种新的治疗选择。